Genetic Technologies (GENE) Institutional Ownership → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free GENE Stock Alerts $2.28 -0.01 (-0.44%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Genetic Technologies (NASDAQ:GENE)CurrentInstitutional OwnershipPercentage0.63%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$2.08MNumber ofInstitutional Sellers(last 12 months)0 Get GENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Genetic Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GENE Institutional Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Genetic Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2024 BNP Paribas Financial Markets9,100$26K0.0%N/A0.236% 11/7/2023 Scarborough Advisors LLC548,372$417K0.0%+5,054.8%2.850% 3/6/2023 OLD Mission Capital LLC70,241$65K0.0%+109.7%0.365% 11/22/2022 Continental Investors Services Inc.32,000$47K0.0%N/A0.208% 11/14/2022 OLD Mission Capital LLC33,499$39K0.0%N/A0.218% 8/13/2021 Jump Financial LLC10,657$45K0.0%N/A0.069% 8/11/2021Susquehanna Fundamental Investments LLC36,172$154K0.0%-44.0%0.235% 5/17/2021 Hennion & Walsh Asset Management Inc.10,072$42K0.0%N/A0.067% 5/17/2021 Goldman Sachs Group Inc.21,602$90K0.0%N/A0.144% 2/12/2021 Credit Suisse AG20,836$75K0.0%N/A0.139% 12/11/2020Virtu Financial LLC23,954$83K0.0%+35.4%0.177% 11/13/2020 Morgan Stanley10,447$36K0.0%+109.1%0.077% 11/12/2020 Group One Trading L.P.14,200$49K0.0%N/A0.105% 8/7/2020Virtu Financial LLC17,689$40K0.0%N/A0.208% (Data available from 1/1/2016 forward) GENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GENE shares? During the previous two years, the following institutional investors and hedge funds held shares of Genetic Technologies shares: Scarborough Advisors LLC ($417K), OLD Mission Capital LLC ($65K), and Continental Investors Services Inc. ($47K), BNP Paribas Financial Markets ($26K).Learn more on GENE's institutional investors. What percentage of Genetic Technologies stock is owned by institutional investors? 0.63% of Genetic Technologies stock is owned by institutional investors. Learn more on GENE's institutional investor holdings. Which institutional investors have been buying Genetic Technologies stock? The following institutional investors have purchased Genetic Technologies stock in the last 24 months: Scarborough Advisors LLC ($537.73K), OLD Mission Capital LLC ($70.24K), Continental Investors Services Inc. ($32K), and BNP Paribas Financial Markets ($9.10K). How much institutional buying is happening at Genetic Technologies? Institutional investors have bought a total of 649,075 shares in the last 24 months. This purchase volume represents approximately $2.63M in transactions. Related Companies: BCDA Major Shareholders COEP Major Shareholders IKT Major Shareholders CELZ Major Shareholders TVGN Major Shareholders FNCH Major Shareholders PMCB Major Shareholders SNTI Major Shareholders ELOX Major Shareholders APTO Major Shareholders This page (NASDAQ:GENE) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA once-in-a-century investment opportunityStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.